rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Andrew Spaventa

Director

Company insider

Files Form 4 as: Director, Aspen Neuroscience; Chief Executive Officer, Singular Genomics Systems.

Every Form 4 they filed

In numbers

Trades disclosed
79
Buys
2
Sells
4
Bought
$49K
Sold
$37K
Companies
2
Companies where not an officer
1
First trade
1 Jun 2021
Last trade
2 Nov 2026
Last filed
2 Nov 2026

Companies traded

Where they are an officer
Singular Genomics SystemsDirector, Officer · last 21 Feb 20252 buys · 4 sells
Everywhere else they filed: board seats, 10% stakes, other companies
ASPE Aspen NeuroscienceDirector · Biotechnology · last 2 Nov 20260 buys · 0 sells

Activity over time

1 Dec 2024 – 1 Nov 2026
10Dec 24Jun 25Dec 25May 26Nov 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
2 Nov 2026filed 2 Nov 2026ASPE Aspen NeuroscienceBiotechnologySEC FORM 4 Code C—70,194filing
2 Nov 2026filed 2 Nov 2026ASPE Aspen NeuroscienceBiotechnologySEC FORM 4 Code C—180,221filing
2 Nov 2026filed 2 Nov 2026ASPE Aspen Neuroscienceoption or derivative · BiotechnologySEC FORM 4 Code C—70,194filing
2 Nov 2026filed 2 Nov 2026ASPE Aspen Neuroscienceoption or derivative · BiotechnologySEC FORM 4 Code C—180,221filing
21 Feb 2025filed 25 Feb 2025Singular Genomics Systemsoption or derivativeSEC FORM 4 Code D$47K42,881 at $1.10filing
21 Feb 2025filed 25 Feb 2025Singular Genomics Systemsoption or derivativeSEC FORM 4 Code D—33,333 at $0.00filing
21 Feb 2025filed 25 Feb 2025Singular Genomics Systemsoption or derivativeSEC FORM 4 Code D—15,555 at $0.00filing
21 Feb 2025filed 25 Feb 2025Singular Genomics Systemsoption or derivativeSEC FORM 4 Code D$87K4,374 at $20.00filing
21 Feb 2025filed 25 Feb 2025Singular Genomics Systemsoption or derivativeSEC FORM 4 Code D$457K22,874 at $20.00filing
21 Feb 2025filed 25 Feb 2025Singular Genomics SystemsSEC FORM 4 Code D—325filing
21 Feb 2025filed 25 Feb 2025Singular Genomics SystemsSEC FORM 4 Code D—5,271filing
21 Feb 2025filed 25 Feb 2025Singular Genomics SystemsSEC FORM 4 Code D—137,629filing
21 Feb 2025filed 25 Feb 2025Singular Genomics SystemsSEC FORM 4 Code D—85filing
14 Feb 2025filed 14 Feb 2025Singular Genomics SystemsSEC FORM 4 Sold$16K800 at $19.89filing
14 Feb 2025filed 14 Feb 2025Singular Genomics SystemsSEC FORM 4 Code G—1,107 at $0.00filing
14 Feb 2025filed 14 Feb 2025Singular Genomics SystemsSEC FORM 4 Code G—1,107 at $0.00filing
12 Feb 2025filed 14 Feb 2025Singular Genomics Systemsoption or derivativeSEC FORM 4 Code M—1,907 at $0.00filing
12 Feb 2025filed 14 Feb 2025Singular Genomics SystemsSEC FORM 4 Code M—1,907filing
16 Dec 2024filed 17 Dec 2024Singular Genomics SystemsSEC FORM 4 Sold$3,629180 at $20.16filing
16 Dec 2024filed 17 Dec 2024Singular Genomics SystemsSEC FORM 4 Code G—306 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Not placed6

Buys in green, sells in red, by the company’s sector.

Related people

Nobody else traded the same names lately.